文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

高剂量容积CT减少前列腺癌放疗观察者间勾画差异与PTV外扩

Evaluation of high dose volumetric CT to reduce inter-observer delineation variability and PTV margins for prostate cancer radiotherapy.
PubMed 文献 · Radiother Oncol · 2017-08-28

HDVCT的Jaccard指数显著高于常规CT(平均差0.03,p=0.011),HDVCT与MRI均可在前列腺尖部较常规CT减少2mm PTV外扩。

要点

  • HDVCT勾画一致性显著优于常规CT,Jaccard指数平均差0.03(p=0.011)。
  • 观察者间差异在前列腺尖部最大,HDVCT和MRI均可在尖部减少2mm PTV。
  • 观察者间勾画差异仍是系统误差的重要来源,现有成像下所需外扩仍大于常规实践。

核心结论

  • HDVCT用于放疗计划可减少观察者间勾画差异而无需依赖MRI,并允许在前列腺尖部将PTV减少2mm。
  • 观察者间勾画差异仍是系统误差的重要来源,任何成像方式下为覆盖残余误差所需的外扩仍大于当前典型实践所用外扩。

研究设计与样本

  • 采用320排容积CT扫描仪,其16cm宽探测器覆盖可单圈完成前列腺容积采集。
  • 由5名放疗科医生勾画前列腺。

主要发现

  • CCT、HDVCT和MR的观察者间差异分别为2.0±0.6mm、1.9±0.4mm和1.8±0.4mm,最大差异位于尖部区域。
  • 与MR比较,观察者使用CCT勾画的变异大于HDVCT,尤其在尖部。
  • HDVCT的Jaccard指数显著高于CCT,平均差0.03(p=0.011)。
  • MRI与HDVCT均提供较CCT在前列腺尖部减少2mm PTV外扩的机会。

临床怎么用

  • 对于无MRI条件的前列腺癌放疗计划,可考虑采用HDVCT以减少勾画差异并支持尖部PTV外扩减少2mm。
  • 需注意即使采用HDVCT或MRI,为覆盖残余观察者间误差所需的外扩仍大于当前典型实践所用外扩。

局限性

  • 研究聚焦于前列腺勾画,未报告其他靶区或危及器官的观察者间差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim was to determine whether the enhanced soft tissue contrast provided by high-dose volumetric CT (HDVCT) can reduce inter-observer variability in delineating prostate compared to helical conventional CT (CCT) scans and 3T MRI scans for patients undergoing radical prostate cancer radiotherapy. Secondly, to quantify the potential PTV reduction with decreased inter-observer variability. MATERIALS AND METHODS: A 320 slice volumetric CT scanner was used. The wide-detector coverage of 16cm enabled volumetric image acquisition of prostate gland in one rotation. Three imaging studies were performed on ten patients. CCT and HDVCT were performed consecutively at the same coordinate system followed by MRI. Five radiation oncologists delineated the prostate. RESULTS: The inter-observer variability is 2.0±0.6, 1.9±0.4 and 1.8±0.4mm for CCT, HDVCT and MR respectively with the maximum at the apex region. Comparing inter-observer difference variability between CCT and HDVCT with MR indicates that observers have larger variations in contouring using CCT than HDVCT especially at apex. Jaccard index of HDVCT is significantly higher than CCT with a mean difference of 0.03 (p=0.011). Both MRI and HDVCT provide the opportunity for a 2mm PTV margin reduction at the apex compared to CCT. CONCLUSION: Inter-observer variability in delineation remains an important source of systematic error. HDCTV for treatment planning reduces this error without recourse to MRI and permits a PTV reduction of 2mm at the apex. The margins required to account for residual error with any imaging modality are still greater than are used in typical current practice.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Alasti H, Cho YB, Catton C, et al. Evaluation of high dose volumetric CT to reduce inter-observer delineation variability and PTV margins for prostate cancer radiotherapy. Radiother Oncol. 2017. PMID: 28859933. doi:10.1016/j.radonc.2017.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。